Postponement Annual Shareholders Meeting - Amendment financial calendar
Leuven, BELGIUM - April 5, 2024 - 02:00 PM CET Oxurion NV (Euronext Brussels:

   OXUR), a biopharmaceutical company headquartered in Leuven, today made the
           following announcement regarding its financial calendar.

Due to administrative reasons, the annual accounts of the Company have not been
finalized yet. Hence, the Company has decided to postpone its Annual
Shareholders Meeting to Thursday May 16, 2024.
The financial calendar (https://ir.oxurion.com/events-presentations) on the
Company website has been updated accordingly.
About Oxurion
Oxurion (Euronext Brussels: OXUR) is engaged in developing next-generation standard of care ophthalmic therapies for the treatment of retinal disease. Oxurion is based in Leuven, Belgium. More information is available at www.oxurion.com (http://www.oxurion.com).
Please contact for additional information:
+-------------------------------------+----------------------------------------+
|Oxurion NV |Backstage Communication | |Pascal Ghoson |Jurgen Vluijmans | |Chief Executive Officer |Partner | |pascal.ghoson@oxurion.com |jurgen@backstagecom.be | |(mailto:pascal.ghoson@oxurion.com) |(mailto:jurgen@backstagecom.be) | | | | +-------------------------------------+----------------------------------------+
Â